JP2014198723A5 - - Google Patents

Download PDF

Info

Publication number
JP2014198723A5
JP2014198723A5 JP2014136302A JP2014136302A JP2014198723A5 JP 2014198723 A5 JP2014198723 A5 JP 2014198723A5 JP 2014136302 A JP2014136302 A JP 2014136302A JP 2014136302 A JP2014136302 A JP 2014136302A JP 2014198723 A5 JP2014198723 A5 JP 2014198723A5
Authority
JP
Japan
Prior art keywords
prophylactic
therapeutic agent
agent according
indeno
furan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014136302A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014198723A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014136302A priority Critical patent/JP2014198723A/ja
Priority claimed from JP2014136302A external-priority patent/JP2014198723A/ja
Publication of JP2014198723A publication Critical patent/JP2014198723A/ja
Publication of JP2014198723A5 publication Critical patent/JP2014198723A5/ja
Pending legal-status Critical Current

Links

JP2014136302A 2011-01-17 2014-07-01 口腔内分散性製剤 Pending JP2014198723A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014136302A JP2014198723A (ja) 2011-01-17 2014-07-01 口腔内分散性製剤

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2011007371 2011-01-17
JP2011007371 2011-01-17
JP2011227333 2011-10-14
JP2011227333 2011-10-14
JP2014136302A JP2014198723A (ja) 2011-01-17 2014-07-01 口腔内分散性製剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012535507A Division JP5600747B2 (ja) 2011-01-17 2012-01-16 口腔内分散性製剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016006663A Division JP2016053094A (ja) 2011-01-17 2016-01-15 口腔内分散性製剤

Publications (2)

Publication Number Publication Date
JP2014198723A JP2014198723A (ja) 2014-10-23
JP2014198723A5 true JP2014198723A5 (OSRAM) 2015-02-26

Family

ID=45567081

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2012535507A Expired - Fee Related JP5600747B2 (ja) 2011-01-17 2012-01-16 口腔内分散性製剤
JP2014136302A Pending JP2014198723A (ja) 2011-01-17 2014-07-01 口腔内分散性製剤
JP2016006663A Pending JP2016053094A (ja) 2011-01-17 2016-01-15 口腔内分散性製剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2012535507A Expired - Fee Related JP5600747B2 (ja) 2011-01-17 2012-01-16 口腔内分散性製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016006663A Pending JP2016053094A (ja) 2011-01-17 2016-01-15 口腔内分散性製剤

Country Status (24)

Country Link
US (6) US20120282191A1 (OSRAM)
EP (1) EP2665465A1 (OSRAM)
JP (3) JP5600747B2 (OSRAM)
KR (1) KR20140014134A (OSRAM)
CN (1) CN103429223A (OSRAM)
AR (1) AR084865A1 (OSRAM)
AU (1) AU2012207818B2 (OSRAM)
BR (1) BR112013017600A2 (OSRAM)
CA (1) CA2824430A1 (OSRAM)
CL (1) CL2013002033A1 (OSRAM)
CO (1) CO6791611A2 (OSRAM)
CR (1) CR20130380A (OSRAM)
EA (1) EA201391053A1 (OSRAM)
EC (1) ECSP13012825A (OSRAM)
IL (1) IL227357A0 (OSRAM)
MA (1) MA34908B1 (OSRAM)
MX (1) MX2013008314A (OSRAM)
PE (1) PE20140255A1 (OSRAM)
PH (1) PH12013501512A1 (OSRAM)
SG (1) SG191964A1 (OSRAM)
TW (1) TW201309347A (OSRAM)
UY (1) UY33869A (OSRAM)
WO (1) WO2012099260A1 (OSRAM)
ZA (1) ZA201305567B (OSRAM)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
WO2012103411A2 (en) 2011-01-28 2012-08-02 Zx Pharma, Llc Controlled-release melatonin composition and related methods
JP6245677B2 (ja) * 2012-01-20 2017-12-13 ニプロ株式会社 口腔内崩壊錠
CN103989643B (zh) * 2013-07-26 2018-10-30 武汉先路医药科技有限公司 含有雷美替胺和共聚维酮的片剂
CA2919442A1 (en) * 2013-07-31 2015-02-05 Intelgenx Corp. Instantly wettable oral film dosage form without surfactant or polyalcohol
IL276030B (en) * 2014-02-07 2022-09-01 Sentar Pharmaceuticals Inc Non-toxic systems, from natural materials, for administering medicine under the tongue
CN106389361A (zh) * 2016-03-31 2017-02-15 北京万全德众医药生物技术有限公司 一种含有雷美替胺的口腔崩解片及其制备方法
CN105853379A (zh) * 2016-03-31 2016-08-17 北京万全德众医药生物技术有限公司 一种雷美替胺分散片及其制备工艺
KR20190008265A (ko) 2016-05-06 2019-01-23 피지션즈 씰, 엘엘씨 발레리안 조성물 및 관련 방법
CN106038502A (zh) * 2016-07-01 2016-10-26 北京万全德众医药生物技术有限公司 一种雷美替胺口崩片及其制备方法
US20210113456A1 (en) * 2017-07-13 2021-04-22 Maxinase Life Sciences Limited Pharmaceutical compositions of ramelteon and methods of use thereof
WO2019211159A1 (en) 2018-05-02 2019-11-07 Ferring B.V. Improved pharmaceutical formulations
JP7552146B2 (ja) * 2019-08-28 2024-09-18 小野薬品工業株式会社 イバブラジンを含有する錠剤
CN113243444A (zh) 2020-02-13 2021-08-13 罗盖特公司 作为口香糖中的填充剂的多孔淀粉
JP7611556B2 (ja) * 2020-05-28 2025-01-10 日医工株式会社 服用性、安定性等に優れた医薬組成物
CN115778925A (zh) * 2022-12-26 2023-03-14 湖北广济医药科技有限公司 一种雷美替胺口溶膜剂及其制备方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2884153B2 (ja) * 1996-03-08 1999-04-19 武田薬品工業株式会社 三環性化合物、その製造法および剤
US6034239A (en) 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
DE69739967D1 (de) * 1996-06-14 2010-09-30 Kyowa Hakko Kirin Co Ltd Eine im Mund schnell zerfallende Tablette
JP3460538B2 (ja) 1997-10-08 2003-10-27 救急薬品工業株式会社 速溶性フィルム製剤
WO1999059544A2 (en) * 1998-05-18 1999-11-25 Takeda Chemical Industries, Ltd. Orally disintegrable tablets
EP1153616B1 (en) 1999-02-15 2004-12-01 Sumitomo Pharmaceuticals Company, Limited Tablets quickly disintegrated in the oral cavity
DE60044134D1 (de) 1999-08-26 2010-05-20 Takeda Pharmaceutical Nasenschleimhaut haftende matrix
WO2001076565A1 (fr) 2000-04-12 2001-10-18 Banyu Pharmaceutical Co., Ltd. Compositions et preparations se desintegrant dans la cavite buccale
US7008642B1 (en) * 2001-02-12 2006-03-07 Advanced Cardiovascular Systems, Inc. Compositions for achieving a therapeutic effect in an anatomical structure and methods of using the same
CN1284532C (zh) * 2001-09-28 2006-11-15 株式会社三和化学研究所 有核型速溶崩解性成型品
FR2834890B1 (fr) 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
US20040161459A1 (en) * 2002-12-31 2004-08-19 Ngoc Do Fast-dissolve tablet technology
US20050137247A1 (en) * 2003-12-22 2005-06-23 The Brigham And Women's Hospital, Inc. Methods and compositions for treatment of hypertension
EP1867641A4 (en) * 2005-04-04 2010-01-13 Takeda Pharmaceutical PREVENTIVE OR HEALING AGENT AGAINST DEPRESSION OR ANXIETY
WO2007010173A1 (en) * 2005-07-18 2007-01-25 Colin Lawrence Amess Electrostatic air filter
PE20070698A1 (es) * 2005-11-14 2007-08-17 Teijin Pharma Ltd Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol
FR2894475B1 (fr) * 2005-12-14 2008-05-16 Servier Lab Composition pharmaceutique orodispersible pour administra- -tion oromucosale ou sublinguale d'agomelatine
EP1967211A4 (en) * 2005-12-28 2009-12-30 Takeda Pharmaceutical PROCESS FOR PRODUCING SOLID PREPARATION DISINTEGRATING IN ORAL CAVITY
BRPI0711872A2 (pt) 2006-05-22 2011-12-06 Vanda Pharmaceuticals Inc tratamento para distúrbios depressivos
US7797869B2 (en) * 2006-07-10 2010-09-21 Tollis David R Multi-section display and utility stanchion
WO2008083204A2 (en) * 2006-12-28 2008-07-10 Braincells, Inc. Modulation of neurogenesis by melatoninergic ligands
RU2478375C2 (ru) 2007-03-13 2013-04-10 ДАЙНИППОН СУМИТОМО ФАРМА Ко., ЛТД. Распадающаяся во рту таблетка
JP5600058B2 (ja) * 2007-04-11 2014-10-01 ファーマシューティカル プロダクションズ， インコーポレイテッド メラトニンタブレットならびに調剤及び使用方法
WO2009060318A2 (en) * 2007-07-12 2009-05-14 Teva Pharmaceutical Industries Ltd. Polymorphic forms of ramelteon and processes for preparation thereof
JP2009114113A (ja) * 2007-11-06 2009-05-28 Nipro Corp 口腔内崩壊錠及びその製造方法
JP2009136240A (ja) 2007-12-10 2009-06-25 Lion Corp チューインガム組成物
JP2011522886A (ja) 2008-06-11 2011-08-04 アストラゼネカ・アクチエボラーグ （２ｓ）−（４ｅ）−ｎ−メチル−５−（３−（５−イソプロポキシピリジン）イル）−４−ペンテン−２−アミンを含む舌下組成物
US7833819B2 (en) * 2008-07-23 2010-11-16 Aptina Imaging Corporation Method and apparatus for decreasing storage node parasitic charge in active pixel image sensors
WO2010074753A1 (en) * 2008-12-23 2010-07-01 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
JP2011007371A (ja) 2009-06-23 2011-01-13 Sanyo Electric Co Ltd 空気調和機
JP5513936B2 (ja) * 2010-03-10 2014-06-04 全星薬品工業株式会社 口腔内崩壊製剤
JP5523913B2 (ja) 2010-04-21 2014-06-18 スタンレー電気株式会社 光源装置および照明装置

Similar Documents

Publication Publication Date Title
JP2014198723A5 (OSRAM)
CN103096881B (zh) 含有具有不愉快味道的药物的膜制剂
ES2916649T1 (es) Composiciones y usos para el tratamiento de la esclerosis múltiple
JP2018021046A5 (OSRAM)
JP2017506624A5 (OSRAM)
HK1206246A1 (en) Use of high dose laquinimod for treating multiple sclerosis
WO2008142572A3 (en) Controlled release tablet formulation containing magnesium aluminometasilicate
JP2019535760A5 (ja) ガボキサドールを用いた注意欠陥多動性障害（ａｄｈｄ）の治療方法
HRP20250615T1 (hr) Tradipitant za upotrebu u liječenju gastropareze
JP2014221827A5 (OSRAM)
JP2016530291A5 (OSRAM)
JP2018521007A5 (OSRAM)
JP2017105861A5 (OSRAM)
WO2007031887A3 (en) Extended release pharmaceutical composition of metformin and a process for producing it
JP2016505050A5 (OSRAM)
WO2016015798A9 (en) Orodispersible film composition comprising enalapril for the treatment of hypertension in a pediatric population
JP2021503483A5 (OSRAM)
JP2019507786A5 (OSRAM)
WO2012042197A3 (en) Low dose pharmaceutical composition comprising zanamivir
JP2013032308A5 (OSRAM)
JP2017061488A5 (OSRAM)
JP2009505991A5 (OSRAM)
MX2022012693A (es) Composicion que comprende metilfolato.
FI3600276T3 (fi) Betahistiini tai sen farmaseuttisesti hyväksyttävä suola ja monoamiinioksidaasin inhibiittori käytettäväksi yhden tai useamman huimausoireen hoitamisessa tai ehkäisemisessä kohteessa
JP2017511350A5 (OSRAM)